A Phase 4 interventional study of Ethinylestradiol/Dienogest 0.03mg/2mg in Endometrial Polyp and Endometrial Diseases, sponsored by University of Palermo. Completed at 2 sites in Italy. Open to female participants aged 45 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-04-22.
Sponsored by University of Palermo · Phase 4, Interventional, and Treatment
The presence of a thin endometrium plays an important role in enabling the best conditions for hysteroscopic surgery. Recently, for this purpose, many studies have evaluated the effect of preoperative administration of a variety of drugs. We explored the efficacy of random started 14-day administration of Ethinylestradiol/Dienogest, in rapid preparation of endometrium for hysteroscopic polypectomy.
66 studies on the registry are indexed under Uterine Diseases; 8 are open to participants now.
This study's enrollment of 80 is below the median of 98 across 52 interventional studies indexed under Uterine Diseases.
Browse Uterine Diseases studies →University of Palermo is the lead sponsor of 142 studies on the registry; 28 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Patients with endometrial polyps undergone hysteroscopic polipectomy without endometrial preparation.
Patients with endometrial polyps underwent hysteroscopic polipectomy after starting 14-day treatment with oral Ethinylestradiol/Dienogest 0.03mg/2mg at any time of the menstrual cycle
Drug: Ethinylestradiol/Dienogest 0.03mg/2mg
Endometrial polyps underwent hysteroscopic polipectomy after starting 14-day treatment with oral Ethinylestradiol/Dienogest 0.03mg/2mg at any time of the menstrual cycle
Quality of endometrial preparation
Quality of endometrial preparation assessed visually intraoperatively by the surgeon using a visual analog scale from 0 to 5.
Time frame: 14th day of treatment
This study is completed, as verified in Apr 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Palermo